You may be aware that over the next 3 years the NHS is starting to roll out the provision of Mounjaro (Tirzepatide) injections for weight loss. The first part of this 3-stage roll-out will begin in July 2025.
The year one roll-out of this programme is strictly limited to those with a BMI of Over 40* and 4 out of 5 of the following weight related conditions:
- Hypertension (High Blood Pressure)
- Dyslipidaemia (High Lipids(fats)/Cholesterol)
- Obstructive Sleep Apnoea
- Cardiovascular Disease
- Type II Diabetes Mellitus
(*37.5 for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean ethnic backgrounds)
The injections will be prescribed along side a programme of Behavioural Support for Obesity services, including a reduced calorie diet and increased exercise regime. Patients must engage in this service in order for a prescription to be issued.
As a surgery we are not yet ready to start prescribing this medication, as we are waiting on full training for our clinical staff. Please be assured that, once we are in a position to do so, we will be in contact with those patients who are eligible to discuss their treatment options.